Abk�rzung zur Hauptnavigation Abk�rzung zu den Newsmeldungen Abk�rzung zu den Topstories  
  Barrierefreiheit    Kontakt MedUni Wien    Intranet    MedUni Wien - Shop    Universitätsbibliothek    Universitätsklinikum AKH Wien  
 
ccc_logo_en.gif
 
AKH Wien
 
 
Hauptnavigation
  • Livestream 2021
  • Home
  • Über das CCC
    • Allgemeines
    • Leitung der Organisationseinheit
    • CCC-Office Team
    • Kliniken und Partner
    • Qualitätsmanagement
    • Kontakt
  • PatientInnen
    • Covid-19
    • Allgemeines
    • Cancer School
    • Terminvereinbarung
    • Pflegeambulanz
    • PatientInnenvertretung
    • Links
  • Klinischer Bereich
    • Allgemeines
    • CCC Tumorboards
  • Wissenschaft & Forschung
    • Young CCC
    • CCC-ExpertInnenvideos
    • CCC Forschungscluster
    • CCC Units
    • CCC Platforms
    • Translationale Forschung
    • CCC Best Paper Award
    • CCC-TRIO Symposium
    • Kontakt/Links
  • Lehre
    • CCC Cancer School
    • Vienna International Summer School on Clinical and Experimental Oncology - VSSO
    • CCC Excellence Lecture
    • Interdisziplinäre onkologische Ausbildung
    • Klinisch-Praktisches Jahr (KPJ)
    • PhD Programme
    • Postgraduelle Fort- und Weiterbildung
    • Information/Contact
 
 
Subnavigation
    Inhaltsbereich


    Zurück zur Übersicht
    Journal of surgical oncology. 2021 Jan 5. doi: 10.1002/jso.26361
    The optimal cut-off values for tumor size, number of lesions, and CEA levels in patients with surgically treated colorectal cancer liver metastases: An international, multi-institutional study.
    Kamphues C1,  Andreatos N2,  Kruppa J3,  Buettner S4,  Wang J5,  Sasaki K6,  Wagner D7,  Morioka D8,  Fitschek F9,  Løes IM10,  Imai K11,  Sun J12,  Poultsides G13,  Kaczirek K14,  Lønning PE15,  Endo I16,  Baba H17,  Kornprat P18,  Aucejo FN19,  Wolfgang CL20,  Kreis ME21,  Weiss MJ22,  Margonis GA23
    Author information
    1Department of General, Visceral, and Vascular Surgery, Charité, University Medicine, Campus Benjamin Franklin, Berlin, Germany.
    2Department of Surgery, Cleveland Clinic, Cleveland, Ohio, USA.
    3Department of General, Visceral, and Vascular Surgery, Charité, University Medicine, Campus Benjamin Franklin, Berlin, Germany.
    4Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    5Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    6Department of Surgery, Cleveland Clinic, Cleveland, Ohio, USA.
    7Department of General Surgery, Medical University of Graz, Graz, Austria.
    8Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
    9Department of General Surgery, Medical University of Vienna, Vienna, Austria.
    10Department of Clinical Science and Oncology, Haukeland University Hospital, University of Bergen, Bergen, Norway.
    11Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Kumamoto, Japan.
    12Department of Surgery, Cleveland Clinic, Cleveland, Ohio, USA.
    13Department of Surgery, Stanford University School of Medicine, Stanford, California, USA.
    14Department of General Surgery, Medical University of Vienna, Vienna, Austria.
    15Department of Clinical Science and Oncology, Haukeland University Hospital, University of Bergen, Bergen, Norway.
    16Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
    17Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Kumamoto, Japan.
    18Department of General Surgery, Medical University of Graz, Graz, Austria.
    19Department of Surgery, Cleveland Clinic, Cleveland, Ohio, USA.
    20Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    21Department of General, Visceral, and Vascular Surgery, Charité, University Medicine, Campus Benjamin Franklin, Berlin, Germany.
    22Department of Surgery, Zucker School of Medicine at Hofstra, Northwell Health Cancer Institute, Lake Success, New York, USA.
    23Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
    Abstract

    BACKGROUND AND OBJECTIVES: Despite the long-standing consensus on the importance of tumor size, tumor number and carcinoembryonic antigen (CEA) levels as predictors of long-term outcomes among patients with colorectal liver metastases (CRLM), optimal prognostic cut-offs for these variables have not been established.

    METHODS: Patients who underwent curative-intent resection of CRLM and had available data on at least one of the three variables of interest above were selected from a multi-institutional dataset of patients with known KRAS mutational status. The resulting cohort was randomly split into training and testing datasets and recursive partitioning analysis was employed to determine optimal cut-offs. The concordance probability estimates (CPEs) for these optimal cut offs were calculated and compared to CPEs for the most widely used cut-offs in the surgical literature.

    RESULTS: A total of 1643 patients who met eligibility criteria were identified. Following recursive partitioning analysis in the training dataset, the following cut-offs were identified: 2.95 cm for tumor size, 1.5 for tumor number and 6.15 ng/ml for CEA levels. In the entire dataset, the calculated CPEs for the new tumor size (0.52), tumor number (0.56) and CEA (0.53) cut offs exceeded CPEs for other commonly employed cut-offs.

    CONCLUSION: The current study was able to identify optimal cut-offs for the three most commonly employed prognostic factors in CRLM. While the per variable gains in discriminatory power are modest, these novel cut-offs may help produce appreciable increases in prognostic performance when combined in the context of future risk scores.


    © 2021 The Authors. Journal of Surgical Oncology published by Wiley Periodicals LLC.

    KEYWORDS: colorectal cancer, metastases, prognostic factors

    Publikations ID: 33400818
    Quelle: öffnen
     
    Drucken
     
    ccc_logo_en.gif
    ccc_logo_en.gif
    ccc_logo_en.gif

    Schnellinfo

     
    -- Initiative Krebsforschung / Krebsforschungslauf

    -- Cancer Care
    -- Kliniken und Partner
    -- CCC Cancer School
    -- Young CCC
    -- CCC Tumorboards
    -- CCC Forschungscluster
    -- CCC Units
    -- CCC Platforms
    -- SOPs / Leitlinien
    -- Kontakt
    Zuklappen
     
    Ausklappen
     
     

    Featured

     
     
     
     
     
     
     
     
     
     
     
     
     
    © MedUni Wien |
     Impressum | Nutzungsbedingungen | Kontakt